Margareta Olsson Birgersson
Roche AB Medical Director
Margareta Olsson Birgersson has been working in the Pharmaceutical Industry (Big-Pharma) for eleven years both in Swedish and Nordic/Baltic organizations responsible for Medical affairs, Clinical operations, and Regulatory and Drug safety.
Since December 2011, she has been the Medical Director of Roche Sweden.
She has a background in hte clinical and research field in Cardiology and Internal Medicine.
She is a member of a scientific group led by Professor Jan Nilsson at King Gustaf Vth research institute performing immunohistochemistry studies on the etiology of stenotic aortic valves, between 1991-2000.
She is responsible for building a center of excellence for Grown Up Congenital Heart disease (GUCH) at Karolinska Hospital and initiated a National quality register for GUCH, and acted as director of the register for five years.
She was a member of the Scientific Council of Medicine and Health within the Swedish Research Council between 2007-2012.
Since April 2013 she is a member of the Board of SciLifeLab (Science for Life Laboratory, National Research Institute).